Primary HIV-1 resistance: a new phase in the epidemic?

Editorial

R J Pomerantz. JAMA. 1999 Sep.

. 1999 Sep;282(12):1177-9.

doi: 10.1001/jama.282.12.1177.

No abstract available

Comment on

HIV-1 drug resistance in newly infected individuals.
Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, Parkin N, Markowitz M. Boden D, et al. JAMA. 1999 Sep 22-29;282(12):1135-41. doi: 10.1001/jama.282.12.1135. JAMA. 1999. PMID: 10501116
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD, Richman DD. Little SJ, et al. JAMA. 1999 Sep 22-29;282(12):1142-9. doi: 10.1001/jama.282.12.1142. JAMA. 1999. PMID: 10501117